Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

STADA Arzneimittel AG

+ Add to Watchlist

STDAF:US

30.2000 USD 1.3500 4.28%

As of 20:10:01 ET on 01/05/2015.

Snapshot for STADA Arzneimittel AG (STDAF)

Open: 30.2000 Day's Range: 30.2000 - 30.2000 Volume: 409
Previous Close: 31.5500 52wk Range: 30.2000 - 50.3500 1-Yr Rtn: -

Stock Chart for STDAF

No chart data available.
  • STDAF:US 30.2000
  • 1D
  • 1M
  • 1Y
31.5500
Interactive STDAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for STDAF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 9.0572
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.9370
Est. PEG Ratio 1.1113
Market Cap (M USD) 1,830.93
Shares Outstanding (M) 60.63
30 Day Average Volume 82
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.90%
Cash Dividend (EUR) 0.6600
Dividend Ex-Date 06/05/2014
5 Year Dividend Growth 4.19%
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for STDAF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for STDAF

Stada Arzneimittel AG manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide.

Hartmut RetzlaffChairman-Mgmt BoardHelmut KraftCFO/Member-Mgmt Board
Matthias WiedenfelsChief Business Develop-Mgmt Bd
More Company Profile & Key Executives for STDAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil